GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genetic Signatures Ltd (ASX:GSS) » Definitions » Net Margin %

Genetic Signatures (ASX:GSS) Net Margin % : -290.48% (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Genetic Signatures Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Genetic Signatures's Net Income for the six months ended in Dec. 2023 was A$-10.47 Mil. Genetic Signatures's Revenue for the six months ended in Dec. 2023 was A$3.60 Mil. Therefore, Genetic Signatures's net margin for the quarter that ended in Dec. 2023 was -290.48%.

The historical rank and industry rank for Genetic Signatures's Net Margin % or its related term are showing as below:

ASX:GSS' s Net Margin % Range Over the Past 10 Years
Min: -254.94   Med: -71.76   Max: 8.65
Current: -123.92


ASX:GSS's Net Margin % is ranked worse than
74.77% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.875 vs ASX:GSS: -123.92

Genetic Signatures Net Margin % Historical Data

The historical data trend for Genetic Signatures's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genetic Signatures Net Margin % Chart

Genetic Signatures Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Net Margin %
Get a 7-Day Free Trial Premium Member Only -71.76 -18.52 6.21 8.65 -65.79

Genetic Signatures Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.53 -12.06 -62.28 -69.12 -290.48

Competitive Comparison of Genetic Signatures's Net Margin %

For the Diagnostics & Research subindustry, Genetic Signatures's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genetic Signatures's Net Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genetic Signatures's Net Margin % distribution charts can be found below:

* The bar in red indicates where Genetic Signatures's Net Margin % falls into.



Genetic Signatures Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Genetic Signatures's Net Margin for the fiscal year that ended in Jun. 2023 is calculated as

Net Margin=Net Income (A: Jun. 2023 )/Revenue (A: Jun. 2023 )
=-14.052/21.36
=-65.79 %

Genetic Signatures's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=-10.469/3.604
=-290.48 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genetic Signatures  (ASX:GSS) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Genetic Signatures Net Margin % Related Terms

Thank you for viewing the detailed overview of Genetic Signatures's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genetic Signatures (ASX:GSS) Business Description

Traded in Other Exchanges
N/A
Address
7 Eliza Street, Newtown, Sydney, NSW, AUS, 2042
Genetic Signatures Ltd proprietary PCR solutions and automated workflows routinely screen for multiple infectious diseases in a single test. Rapid and accurate results facilitate improved patient management and healthcare outcomes. GSS continues to expand its global reach with direct representation in Australia, Europe, and the United States, and growing distribution partnerships. The company operates under one business segment which is the research and commercialisation of identifying individual genetic signatures to diagnose diseases and disabilities.